CNKSR2

Chr XX-linked

connector enhancer of kinase suppressor of Ras 2

Also known as: CNK2, KSR2, MAGUIN, MRXSHG

This gene encodes a multidomain protein that functions as a scaffold protein to mediate the mitogen-activated protein kinase pathways downstream from Ras. This gene product is induced by vitamin D and inhibits apoptosis in certain cancer cells. It may also play a role in ternary complex assembly of synaptic proteins at the postsynaptic membrane and coupling of signal transduction to membrane/cytoskeletal remodeling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]

OMIMResearchGenerating clinical summary…
LOFmechanismX-linkedLOEUF 0.181 OMIM phenotype
Clinical SummaryCNKSR2
🧬
Gene-Disease Validity (ClinGen)
X-linked complex neurodevelopmental disorder · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
56 unique Pathogenic / Likely Pathogenic· 169 VUS of 381 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.18LOEUF
pLI 1.000
Z-score 5.57
OE 0.07 (0.030.18)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.61Z-score
OE missense 0.47 (0.420.54)
177 obs / 372.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.07 (0.030.18)
00.351.4
Missense OE?0.47 (0.420.54)
00.61.4
Synonymous OE?0.83
01.21.6
LoF obs/exp: 3 / 41.9Missense obs/exp: 177 / 372.9Syn Z: 1.52
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCNKSR2-related intellectual disability with epilepsyLOFXLR

This gene — mechanism propensity

DN
0.3793th %ile
GOF
0.5367th %ile
LOF
0.80top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 95% of P/LP variants are LoF · LOEUF 0.18 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

381 submitted variants in ClinVar

Classification Summary

Pathogenic35
Likely Pathogenic21
VUS169
Likely Benign33
Benign6
Conflicting6
35
Pathogenic
21
Likely Pathogenic
169
VUS
33
Likely Benign
6
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
35
0
0
0
35
Likely Pathogenic
18
3
0
0
21
VUS
6
153
7
3
169
Likely Benign
0
10
6
17
33
Benign
0
2
1
3
6
Conflicting
6
Total591681423270

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

108 pathogenic / likely-pathogenic (of 119) ClinVar copy-number / structural variants overlap CNKSR2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CNKSR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →